Medtric Biotech develops eco-friendly antimicrobial technologies for the medical, industrial, and agricultural markets.
Medtric aims to provide a measurable difference by delivering clinically robust and economically sensible wound care solutions. They formed the company with this simple vision in mind. Focus on Innovation: Their company's focus is on developing innovative products to advance patient care. The company's flagship technology was developed collaboratively at leading research and medical institutions. Their nanoscale-based therapy was specifically engineered to protect wounds against infection and advance the healing process. Strategy for Growth: As they look to the future, their strategy is to enter the expanding clinical and over the counter wound care markets. It will also leverage this platform to penetrate alternative applications including the treatment of acne and other topical infections. Their strategy ensures a strong foundation with expansive capabilities.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 14, 2013 | Pre-seed | $100K | 1 | Emerging Innovations Fund | — | Detail |
Dec 6, 2012 | Grant | $179.57K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Emerging Innovations Fund | Yes | Pre-seed |
National Science Foundation | Yes | Grant |